相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Jane C. Davies et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Pitfalls of Drug Development: Lessons Learned from Trials of Denufosol in Cystic Fibrosis
Richard B. Moss
JOURNAL OF PEDIATRICS (2013)
Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
Juan L. Mendoza et al.
CELL (2012)
Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
Wael M. Rabeh et al.
CELL (2012)
Correction of F508del-CFTR Trafficking by the Sponge Alkaloid Latonduine Is Modulated by Interaction with PARP
Graeme W. Carlile et al.
CHEMISTRY & BIOLOGY (2012)
Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
Patrick A. Flume et al.
CHEST (2012)
Ivacaftor potentiation of multiple CFTR channels with gating mutations
Haihui Yu et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Long term effects of denufosol tetrasodium in patients with cystic fibrosis
Felix Ratjen et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype
Jenny K. Gustafsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia
Paolo Scudieri et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung Disease
Mayumi Oakland et al.
MOLECULAR THERAPY (2012)
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Alejandro A. Pezzulo et al.
NATURE (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M. Wilschanski et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial Cells
Wan Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
New clinical diagnostic procedures for cystic fibrosis in Europe
K. De Boeck et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
Steven M. Rowe et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
P. M. George et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Influence of cell background on pharmacological rescue of mutant CFTR
Nicoletta Pedemonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Cystic fibrosis and survival to 40 years: a case-control study
N. J. Simmonds et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
Patrick H. Thibodeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M. Hutt et al.
NATURE CHEMICAL BIOLOGY (2010)
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Frank J. Accurso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Tsukasa Okiyoneda et al.
SCIENCE (2010)
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion
Mary Abigail S. Garcia et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mutation-Specific Potency and Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Potentiators
Antonella Caputo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation
Tzyh-Chang Hwang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Mechanisms for Rescue of Correctable Folding Defects in CFTRΔF508
Diane E. Grove et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Chloride channels as drug targets
Alan S. Verkman et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage
Agustin Garcia-Caballero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CFTR function and prospects for therapy
John R. Riordan
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit
Bjoern Christian Schroeder et al.
CELL (2008)
Cystic fibrosis, vector-mediated gene therapy, and relevance of toll-like receptors: A review of problems, progress, and possibilities
Timothy J. Atkinson
CURRENT GENE THERAPY (2008)
An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years
Margaret E. Hodson et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease
Andrew J. Hirsh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
TMEM16A confers receptor-activated calcium-dependent chloride conductance
Young Duk Yang et al.
NATURE (2008)
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function
Adrian W. R. Serohijos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity
Antonella Caputo et al.
SCIENCE (2008)
Sodium channels and cystic fibrosis
Scott H. Donaldson et al.
CHEST (2007)
Correctors of protein trafficking defects identified by a novel high-throughput screening assay
Graeme W. Carlile et al.
CHEMBIOCHEM (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Liat Linde et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms
Monica Roxo-Rosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator
J. Michael Younger et al.
CELL (2006)
Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the α-glucosidase inhibitor miglustat
C Norez et al.
FEBS LETTERS (2006)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin
CA Farinha et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phenylglycine and sulfonamide correctors of defective ΔF508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating
N Pedemonte et al.
MOLECULAR PHARMACOLOGY (2005)
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains
P Vergani et al.
NATURE (2005)
Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes
M Sharma et al.
JOURNAL OF CELL BIOLOGY (2004)
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease
AJ Hirsh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nanomolar affinity small molecule correctors of defective ΔF508-CFTR chloride channel gating
H Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07
O Zegarra-Moran et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator ΔF508
ACV deCarvalho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells
D Penque et al.
LABORATORY INVESTIGATION (2000)
Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels
F Wang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
分享论文
